Skip to main content
. 2023 Mar 14;11(4):e546–e555. doi: 10.1016/S2214-109X(23)00045-1

Figure 1.

Figure 1

Assumed cumulative number of countries introducing the novel vaccine by year for the base-case and routine-only scenarios

Base-case assumes introduction of routine vaccination for those aged 9 years and one-off vaccination for those aged 10 years and older. Routine-only assumes introduction of routine vaccination among those aged 9 years only. The earliest vaccine introduction occurs in 2028 and the latest in 2047. See appendix 5 (pp 26–33) for full details.